Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousAntineoplastic Combined Chemotherapy ProtocolsWhole-Body IrradiationBone and BonesHematopoietic Stem Cell TransplantationTransplantation ConditioningAnemia, AplasticTreatment OutcomeLeukemiaLiver TransplantationCyclophosphamideTransplantation ChimeraGraft SurvivalCombined Modality TherapyTissue DonorsBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityBone Marrow DiseasesTransplantation, IsogeneicRecurrenceKidney TransplantationTime FactorsHematopoiesisLeukemia, Myeloid, AcuteSurvival AnalysisMice, Inbred C57BLLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-LymphomaRadiation ChimeraBone Marrow ExaminationImmunosuppressive AgentsHematologic NeoplasmsRemission InductionLymphoma, Non-HodgkinChemotherapy, AdjuvantGraft RejectionHepatic Veno-Occlusive DiseaseLeukemia, MyeloidSurvival RateBone RemodelingFollow-Up StudiesBone Marrow NeoplasmsAcute DiseaseRetrospective StudiesStem Cell TransplantationTransplantation ImmunologyGraft vs Host ReactionPrognosisImmunosuppressionDisease-Free SurvivalLymphocyte DepletionEtoposideLeukocyte TransfusionHeart TransplantationActuarial AnalysisMyelodysplastic SyndromesSevere Combined ImmunodeficiencyColony-Forming Units AssayT-LymphocytesCytarabineHematologic DiseasesCarmustineHLA AntigensChimeraLung TransplantationAntineoplastic AgentsCyclosporineBone DensityGranulocyte Colony-Stimulating FactorLymphocyte TransfusionMelphalanMethotrexateProspective StudiesLeukocyte CountNuclear FamilyOrgan TransplantationHodgkin DiseasePancytopeniaLymphomaCell DifferentiationGraft vs Tumor EffectFatal OutcomeGraft vs Leukemia EffectMultiple MyelomaDoxorubicinCytomegalovirus InfectionsMice, Inbred BALB CSpleenFlow CytometryBone NeoplasmsBone ResorptionSalvage Therapy